Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants

Inactivation of the Ataxia Telangiectasia Mutated gene in chronic lymphocytic leukemia results in resistance to p53-dependent apoptosis and inferior responses to treatment with DNA damaging agents. Hence, p53-independent strategies are required to target Ataxia Telangiectasia Mutated-deficient chron...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Haematologica
Autors principals: Agathanggelou, Angelo, Weston, Victoria J., Perry, Tracey, Davies, Nicholas J., Skowronska, Anna, Payne, Daniel T., Fossey, John S., Oldreive, Ceri E., Wei, Wenbin, Pratt, Guy, Parry, Helen, Oscier, David, Coles, Steve J., Hole, Paul S., Darley, Richard L., McMahon, Michael, Hayes, John D., Moss, Paul, Stewart, Grant S., Taylor, A. Malcolm R., Stankovic, Tatjana
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2015
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5004424/
https://ncbi.nlm.nih.gov/pubmed/25840602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.115170
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars